The European market for Patient monitoring is estimated at $ 4.57 Billion in 2018 and is expected to reach $6.44Billion by 2023 at a CAGR of 7.10%.
Patient Monitoring Systems enable efficient healthcare delivery to patients outside conventional hospital or clinical settings by transmitting real-time patient date for clinical review which helps in reducing mortality rates and facilitate efficient use of medical resources. These patient monitoring services help in avoiding emergency overcrowding, manage huge number of patients and enhanced maintenance of electronic health records (EHR). Recently the market has gained immense focus due to the government measures to cut down hospital expenditures and reduce hospital stays.
The Europe Patient monitoring market is segmented on the basis of disease condition like neurology, hemodynamic, cardiac, fetal and neonatal, respiratory, multiparameter, remote patient monitors, temperature and weight monitoring systems.
Cardiac monitoring segment the largest segment in Europe patient monitoring market and is predicted to maintain its strong share till 2023 due to increasing demand for ECG (Electro Cardiogram) devices and increased rate of cardiac and other comorbid conditions such as diabetes and high blood pressure The respiratory monitoring segment is the fastest growing during the forecast period.
Furthermore, on the basis of geography, the European patient monitoring market is segmented into UK, Spain, Italy, Germany and France. Growth in the region is expected to be slow in the forecast period due to factors such as decreasing birth rates, irregular reimbursement policies and reduced number of beds in hospitals. UK is the largest market within the followed by Germany encouraged by the widespread proliferation of high-speed internet and its related services. Rapidly growing aging population vulnerable to diseases, government policies to trim down healthcare expenditure are the major factors driving the market growth. On the other side, patient privacy concerns & lack of proper reimbursements policies and the high cost of Patient Monitoring systems are inhibiting the growth of the market.
Some of the key players in the Europe Patient Monitoring market are Abbott Laboratories, Johnson & Johnson Inc., Covidien, Drager Medical GmbH, GE Healthcare, , Mortara Instrument Inc., Natus, Nihon Kohden, Masimo Corporation, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited and Welch Allyn.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Application
5.1.1 Neuromonitoring Devices
5.1.1.1 Electroencephalograph (EEG)
5.1.1.2 Transcranial Doppler (TCD)
5.1.1.3 Magnetoencephalograph (MEG)
5.1.1.4 Cerebral Oximeters
5.1.1.5 Intracranial Pressure Monitors (ICP)
5.1.2 Hemodynamic Monitoring Devices
5.1.2.1 Blood Pressure Monitors
5.1.2.2 Blood Glucose Monitors
5.1.2.3 Blood Gas and Electrolyte Analyzers
5.1.2.4 Cholesterol Analyzers
5.1.3 Cardiac Monitoring Devices
5.1.3.1 Electrocardiogram (ECG)
5.1.3.2 Event Monitors
5.1.3.3 Implantable Loop Recorder (ILR)
5.1.3.4 Cardiac Output Monitoring Devices
5.1.4 Fetal and neonatal Monitoring Devices
5.1.4.1 Ultra Sound Fetal Dopplers
5.1.4.2 Internal Fetal Monitors
5.1.5 Respiratory Monitoring Devices
5.1.5.1 Capnographs
5.1.5.2 Spirometers
5.1.5.3 Anesthesia Monitors
5.1.5.4 Sleep Apnea Monitoring Devices
5.1.5.5 Pulse Oximeters
5.1.6 Multi-Parameter Monitoring Devices
5.1.6.1 High-Acuity Monitors
5.1.6.2 Mid-Acuity Monitors
5.1.6.3 Low-Acuity Monitors
5.1.7 Temperature Monitoring Devices
5.1.8 Weight Monitoring Devices
5.1.9 Remote Patient Monitoring Devices
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Drager Medical GmbH
8.3 GE Healthcare
8.4 Johnson & Johnson Inc
8.5 Masimo Corporation
8.6 Medtronic
8.7 Omron Healthcare
8.8 Mindray Medical
8.9 Mortara Instrument Inc
8.10 Nonin Medical
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
